Investors Grab BLCM Even Cheaper Than Its Secondary Stock Offering
July 19, 2018 at 13:10 PM EDT
Looking back to 93 days ago, Bellicum Pharmaceuticals Inc (BLCM) priced a 8,000,000 share secondary stock offering at $7.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..